Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New technology provides insights into foot-and-mouth disease
The insight could lead to improved methods for preventing foot-and-mouth disease.
Researchers observe virus-host cell interaction

A new understanding of the interaction between foot-and-mouth disease virus (FMDV) and host cells could lead to improved methods for preventing the disease.

The research, supported by The Pirbright Institute, was triggered by advances in cryo-electron microscopy (cryo-EM)1. Unlike other techniques, this technology allows scientists to study samples at very low temperatures and view them in their natural state.

Prior research to view FMDV in such detail revealed an exposed flexible ‘loop’ on the surface of the otherwise smooth outer shell (GH loop). FMDV infects a host cell by binding to a receptor protein on the cell surface called intern via the GH loop.

Up to now, it has been impossible to see the process of engagement due to the integrin binding part being so flexible. Improved imaging techniques have allowed biologists to observe the virus-host cell interaction more effectively and overcome the previous challenge of visualising the flexible attachment site.

“There are seven distinct serotypes of FMDV, but in this study, we focussed on serotype O as it poses the most significant threat globally and is used in around 80 per cent of vaccines,” explained Dr Julian Seago from The Pirbright Institute.

“Using high-resolution cryo-EM we were able to observe that FMDV extends its GH loop up and away from the virus surface to engage the integrin receptor.

“Detailed mapping of the binding mechanisms between FMDV and host cells may ultimately enable the design of new anti-virals capable of inhibiting the virus from entering host cells. Furthermore, our use of cryo-EM in this research would suggest its usefulness in studies of other virus-receptor interactions.” 

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.